Literature DB >> 31310842

Diagnostic and Treatment Algorithm for Chronic Nodular Prurigo.

Hartmut F Ständer1, Sarina Elmariah2, Claudia Zeidler3, Mary Spellman4, Sonja Ständer5.   

Abstract

Chronic nodular prurigo (CNPG) is a subtype of chronic prurigo, also described as prurigo nodularis, and a chronic skin condition characterized by intensely pruritic nodular lesions. Although the exact cause of CNPG is unknown, it appears to result from a repetitive itch-scratch cycle induced by neuronal sensitization to chronic pruritus. CNPG is associated with an underlying dermatologic condition in about half of patients, and can also be attributed to systemic, neurologic, psychogenic, or unknown causes. For most patients, multiple underlying causes are identified. Patients with CNPG often experience impaired quality-of-life, sleep disturbance, anxiety, and depression. To encourage consistent and accurate diagnosis and treatment of CNPG across regions, we are proposing a diagnostic and treatment algorithm, which includes initial assessment of core symptoms, detailed dermatological history and clinical examination, patient-reported outcomes, diagnostic workup, and recommended therapies. This information is supplemented with photographs to illustrate clinical appearance and disease severity. As CNPG is often multifactorial and it can take months to years for lesions to heal, interdisciplinary cooperation and long-term management are important.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  algorithm; chronic nodular prurigo; diagnosis; prurigo nodularis; prurigo scoring; prurigo severity; treatment

Year:  2019        PMID: 31310842     DOI: 10.1016/j.jaad.2019.07.022

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Chronic Nodular Prurigo: A European Cross-sectional Study of Patient Perspectives on Therapeutic Goals and Satisfaction.

Authors:  Manuel P Pereira; Claudia Zeidler; Joanna Wallengren; Jon Anders Halvorsen; Elke Weisshaar; Simone Garcovich; Laurent Misery; Emilie Brenaut; Ekin Şavk; Nikolay Potekaev; Andrey Lvov; Svetlana Bobko; Jacek C Szepietowski; Adam Reich; Agnieszka Bozek; Franz J Legat; Martin Metz; Markus Streit; Esther Serra-Baldrich; Margarida Gonçalo; Michael Storck; Teresa Nau; Vincent Hoffmann; Sabine Steinke; Ina Greiwe; Martin Dugas; Matthias Augustin; Sonja Ständer
Journal:  Acta Derm Venereol       Date:  2021-02-17       Impact factor: 3.875

2.  Nomenclature and clinical phenotypes of atopic dermatitis.

Authors:  Giampiero Girolomoni; Marjolein de Bruin-Weller; Valeria Aoki; Kenji Kabashima; Mette Deleuran; Luis Puig; Ashish Bansal; Ana B Rossi
Journal:  Ther Adv Chronic Dis       Date:  2021-03-26       Impact factor: 5.091

3.  Increased IL-31 expression in serum and tissue protein in prurigo nodularis.

Authors:  Suteeraporn Chaowattanapanit; Rachot Wongjirattikarn; Nipon Chaisuriya; Piti Ungarreevittaya; Pirawan Poosekeaw; Kengkart Winaikosol; Charoen Choonhakarn; Narachai Julanon; Kanin Salao
Journal:  Ther Adv Chronic Dis       Date:  2022-07-19       Impact factor: 4.970

Review 4.  Prurigo Nodularis: A Review of IL-31RA Blockade and Other Potential Treatments.

Authors:  Anthony Bewley; Bernard Homey; Andrew Pink
Journal:  Dermatol Ther (Heidelb)       Date:  2022-08-20

5.  Multiple skin ulceration and itch-scratch cycle in a diabetic patient.

Authors:  Satoshi Murao; Kazutoshi Murao
Journal:  J Diabetes Investig       Date:  2021-05-08       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.